Obeldesivir provided faster symptom relief but did not reduce hospitalization or all-cause mortality in high-risk nonhospitalized patients with COVID-19.

Home > Press release: Just breathe: fighting viral respiratory ... A research team at MHH wants to use the CRISPR-Cas13 system to cut up viral RNA and thus stop the pathogens from multiplying. The ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

Researchers have developed a new way to study how biochemical processes can impair the immune system’s ability to recognize ...

A previously unknown virus in farmed Pacific oysters may hold the key to mass die-offs in the multimillion-dollar industry, ...

Messenger RNA, or mRNA – a technology that can instruct cells to fight disease – has fueled breakthroughs from Covid vaccines ...

Nucleic acid aptamers have attained significant prominence in diagnostics, therapeutics, and medical research owing to their ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

New York City confirms its initial West Nile virus cases for 2025. Two Queens residents are affected. One has West Nile fever ...

Researchers have discovered that a virus living inside the fungus Aspergillus fumigatus significantly boosts the fungus's ...

A study of over 10,000 nasal swabs finds that recent rhinovirus infections, the main cause of the common cold, reduce the ...